Updated on: Saturday, June 01, 2019, 02:33 PM IST

HC bars export of Natco’s generic cancer drug


New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.

Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.

The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.


Bayer has sought directions to the customs authorities to seize and confiscate the consignment.

(To receive our E-paper on whatsapp daily, please click here. We permit sharing of the paper's PDF on WhatsApp and other social media platforms.)

Published on: Friday, March 28, 2014, 12:03 AM IST